Ventilator-associated pneumonia due to Pseudomonas aeruginosa - PubMed (original) (raw)
Ventilator-associated pneumonia due to Pseudomonas aeruginosa
S Crouch Brewer et al. Chest. 1996 Apr.
Abstract
Objective: Ventilator-associated pneumonia (VAP) caused by Pseudomonas aeruginosa has been associated with higher case fatality rates than VAP caused by other bacterial etiologies. The causes of this excess mortality are unclear.
Design: Retrospective review of 38 consecutive ventilated patients with Pseudomonas pneumonia, documented by highly reliable methods. Charts of five additional patients were unavailable for review.
Setting: Medical ICUs of a university-affiliated Veterans Affairs Medical Center and a university-affiliated municipal hospital.
Measurements: Prospectively collected hospital admission acute physiologic and chronic health examination (APACHE) II scores and cause of ICU admission. Retrospectively calculated organ failure and APACHE scores, VAP score. Clinical and microbiologic variables. Antibiotic treatment and outcome. Direct cause of death by standard definitions.
Results: Overall mortality was 69% (26/38), significantly higher than the APACHE II predicted mortality of 42.6% (p=0.037). At least 38% (10/26) of deaths were directly attributable to Pseudomonas VAP. Multivariate analysis of factors associated with death found infectious cause for ICU admission (odds ratio [OR]=8.67; 95% confidence interval [CI], 0.86 to 85.94) and number of organ dysfunctions on the day of diagnosis (OR=1.73, 95% CI, 1.02 to 2.92) were significant. Septic shock from Pseudomonas VAP, septic shock from subsequent infection, and multiple organ dysfunction syndrome were the most common immediate causes of death. Mortality increased linearly with increasing APACHE III score on the day of diagnosis. Of initial antibiotic regimens, 67% (26/36) were considered failures. Persistent pneumonia occurred in 35% of patients while recurrent pneumonia was unusual (1/38).
Conclusions: Development of Pseudomonas pneumonia results in a mortality rate in excess of that due to the presenting illness. The attributable mortality determined by several means appears to approach 40%. The excess mortality appears to be related to the host defense response to the pneumonia rather than any characteristic of the pneumonia. Even standard antibiotic regimens fail frequently and do not prevent the excess mortality. Since at least 38% of deaths can be directly attributable to the Pseudomonas pneumonia, improvement in therapy is needed.
Similar articles
- Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
Bouglé A, Foucrier A, Dupont H, Montravers P, Ouattara A, Kalfon P, Squara P, Simon T, Amour J; iDIAPASON study group. Bouglé A, et al. Trials. 2017 Jan 23;18(1):37. doi: 10.1186/s13063-017-1780-3. Trials. 2017. PMID: 28114979 Free PMC article. Clinical Trial. - Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
Arnold HM, Sawyer AM, Kollef MH. Arnold HM, et al. Respir Care. 2012 Aug;57(8):1226-33. doi: 10.4187/respcare.01556. Epub 2012 Feb 17. Respir Care. 2012. PMID: 22349038 - Impact of superinfection on hospital length of stay and costs in patients with ventilator-associated pneumonia.
Eagye KJ, Nicolau DP, Kuti JL. Eagye KJ, et al. Semin Respir Crit Care Med. 2009 Feb;30(1):116-23. doi: 10.1055/s-0028-1119815. Epub 2009 Feb 6. Semin Respir Crit Care Med. 2009. PMID: 19199193 Review. - [Actualities of adults' ventilator-associated pneumonia].
Svediene S, Ivaskevicius J. Svediene S, et al. Medicina (Kaunas). 2006;42(2):91-7. Medicina (Kaunas). 2006. PMID: 16528124 Review. Lithuanian.
Cited by
- Determination of N-acylhomoserine lactones of Pseudomonas aeruginosa in clinical samples from dogs with otitis externa.
Kušar D, Šrimpf K, Isaković P, Kalšek L, Hosseini J, Zdovc I, Kotnik T, Vengušt M, Tavčar-Kalcher G. Kušar D, et al. BMC Vet Res. 2016 Oct 18;12(1):233. doi: 10.1186/s12917-016-0843-0. BMC Vet Res. 2016. PMID: 27756390 Free PMC article. - Mice Survival and Plasmatic Cytokine Secretion in a "Two Hit" Model of Sepsis Depend on Intratracheal Pseudomonas Aeruginosa Bacterial Load.
Restagno D, Venet F, Paquet C, Freyburger L, Allaouchiche B, Monneret G, Bonnet JM, Louzier V. Restagno D, et al. PLoS One. 2016 Aug 30;11(8):e0162109. doi: 10.1371/journal.pone.0162109. eCollection 2016. PLoS One. 2016. PMID: 27574993 Free PMC article. - Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa.
Lu Q, Girardi C, Zhang M, Bouhemad B, Louchahi K, Petitjean O, Wallet F, Becquemin MH, Le Naour G, Marquette CH, Rouby JJ. Lu Q, et al. Intensive Care Med. 2010 Jul;36(7):1147-55. doi: 10.1007/s00134-010-1879-4. Epub 2010 Apr 16. Intensive Care Med. 2010. PMID: 20397007 - Crystal structure and oligomeric state of the RetS signaling kinase sensory domain.
Jing X, Jaw J, Robinson HH, Schubot FD. Jing X, et al. Proteins. 2010 May 15;78(7):1631-40. doi: 10.1002/prot.22679. Proteins. 2010. PMID: 20112417 Free PMC article. - Rapid expansion and extinction of antibiotic resistance mutations during treatment of acute bacterial respiratory infections.
Chung H, Merakou C, Schaefers MM, Flett KB, Martini S, Lu R, Blumenthal JA, Webster SS, Cross AR, Al Ahmar R, Halpin E, Anderson M, Moore NS, Snesrud EC, Yu HD, Goldberg JB, O'Toole GA, McGann P, Stam JA, Hinkle M, McAdam AJ, Kishony R, Priebe GP. Chung H, et al. Nat Commun. 2022 Mar 9;13(1):1231. doi: 10.1038/s41467-022-28188-w. Nat Commun. 2022. PMID: 35264582 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources